KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lam Research (LRCX) EBITDA (2016 - 2026)

Lam Research has reported EBITDA over the past 18 years, most recently at $2.0 billion for Q1 2026.

  • Quarterly EBITDA rose 31.07% to $2.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.4 billion through Mar 2026, up 40.5% year-over-year, with the annual reading at $5.9 billion for FY2025, 38.39% up from the prior year.
  • EBITDA was $2.0 billion for Q1 2026 at Lam Research, up from $1.8 billion in the prior quarter.
  • Over five years, EBITDA peaked at $2.0 billion in Q1 2026 and troughed at $854.6 million in Q2 2023.
  • The 5-year median for EBITDA is $1.3 billion (2024), against an average of $1.4 billion.
  • Biggest five-year swings in EBITDA: plummeted 42.23% in 2023 and later soared 54.55% in 2025.
  • Tracing LRCX's EBITDA over 5 years: stood at $1.7 billion in 2022, then plummeted by 37.08% to $1.1 billion in 2023, then increased by 26.17% to $1.3 billion in 2024, then soared by 35.71% to $1.8 billion in 2025, then rose by 13.08% to $2.0 billion in 2026.
  • According to Business Quant data, EBITDA over the past three periods came in at $2.0 billion, $1.8 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.